Max Osofsky is a General Partner at Riverside Partners, a private equity firm that invests in middle-market healthcare. See sector focus and contact routes.
Max Osofsky is a General Partner at Riverside Partners, a private equity firm that invests in middle-market healthcare and technology companies, typically those with revenues between $20–$200 million and $5–$25 million in EBITDA. He focuses on the health care, financial services, and investment platform sectors across seed, growth, and expansion stages. Osofsky has played a key role in numerous Riverside investments in healthcare and technology, including the firm’s majority equity investment in Medical Reimbursements of America (MRA). His portfolio also includes companies like UnisLink, which acquired revenue cycle solutions providers AQREVA and Doctors' Resource Specialists.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Waban when building a target list.
Investors like Max Osofsky · Full investor directory · Investor access · Company funding database